
    
      This study is a prospective, multiple center study to evaluate the safety and effectiveness
      of WeFlow-Tbranch single embedded branch thoracic aorta stent graft system in the treatment
      of Stanford type B dissection of the proximal left subclavian artery. It is expected to
      complete the implantation of 120 patients in 29 centers within 12 months, and interim
      follow-up was conducted before discharge, 30 days after surgery, 6 months after surgery and
      12 months after surgery, long-term follow-up will be performed at 24 months postoperatively,
      36 months postoperatively, 48 months postoperatively and 60 months postoperatively.
    
  